Short Interest in Integrated BioPharma, Inc. (OTCMKTS:INBP) Decreases By 25.0%

Integrated BioPharma, Inc. (OTCMKTS:INBP) was the recipient of a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 300 shares, a decline of 25.0% from the February 13th total of 400 shares. Based on an average trading volume of 32,600 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the shares of the company are sold short.

Integrated BioPharma Stock Performance

OTCMKTS INBP traded up $0.01 during trading on Monday, reaching $0.32. 32,815 shares of the company traded hands, compared to its average volume of 19,621. The stock’s 50 day moving average price is $0.34 and its two-hundred day moving average price is $0.30. The company has a market cap of $9.60 million, a price-to-earnings ratio of 10.57 and a beta of 0.89. Integrated BioPharma has a 1-year low of $0.16 and a 1-year high of $0.42.

About Integrated BioPharma

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.